info@liveleaf.com
(877) 925-2888

 

NEWS
_________________________________

LIVELEAF, INC. LICENSES PHYTOBIOLOGICS TECHNOLOGY TO INQPHARM GROUP’S ANIMAL HEALTH DIVISION

Published April 4, 2016

San Carlos, California and Kuala Lumpur, Malaysia (April 4, 2016)– In a strategic move to further strengthen its Animal Health portfolio, InQpharm Group has acquired from LiveLeaf, Inc. a license for its phytobiologics platform, one of the most significant recent developments in the field of nature-based health technologies. The license for production livestock and equine use initially extends rights for Europe and portions of the Asia Pacific, with InQpharm having an option on other significant territories.

LiveLeaf’s patented technology derives unprecedented bioactivity from botanical compounds with a well-documented history of safe use. One of the main benefits is that it significantly improves the gastrointestinal health of young food-producing animals, a breakthrough for keeping them on the optimal natural growth curve in antibiotic-free programs. LiveLeaf’s Grazix® Animal Health products utilize phytobiologics specially developed for livestock.  LiveLeaf phytobiologics were originally intended for human use and have been introduced as LiveXtract® in exceptionally fast-acting and natural digestive care products.

InQpharm’s Vetrinol™, Vetrinol™ Plus and Vetrinol™ Neo product lines were successfully introduced in Europe for the prevention and treatment of reducing somatic cell count, sub-clinical mastitis and calf diarrhea. This latest acquisition will give InQpharm critical mass as a leader in the field of bioactive natural alternatives for the animal health industry.

“We are excited to add this breakthrough nature-based technology to our already successful and highly diverse group of innovative offerings. This agreement is evidence of our continued commitment to seek out novel solutions to the challenges of sustainable food production,” said Thomas Hafner, founder and CEO of Zaluvida, InQpharm’s parent company. “These products are perfectly aligned with our focus on natural alternatives to reduce antimicrobial overuse in growth promotion,” he added.

Commenting on the deal, Alex Huang, founder and CEO of LiveLeaf said, “We are delighted to have found a like-minded partner to extend our reach in deploying this important breakthrough worldwide.  Our phytobiologics provide production farmed animals the first practical and consistent delivery of immune benefits previously only available from a natural field grazing diet.  InQpharm further validates the potential of our technology to help meet the world’s growing demand for protein without compromising the health of future generations.”

About InQpharm

InQpharm is a global life science company that develops best-in-class and first-in-class healthcare solutions based on proprietary bioactive platform technologies. Already a true game-changer and market leader in several consumer health categories, InQpharm’s innovative solutions nourish, protect and improve the lives of global consumers and animals alike.

Founded and headquartered in Kuala Lumpur, Malaysia, the company has offices in Germany, The Netherlands, United Kingdom and in the United States with Switzerland to open by mid-year. These InQpharm facilities around the globe provide an end-to-end ecosystem of centers of excellence – from molecule and compound discovery to delivering ground breaking products to the end consumer. InQpharm is fully owned by the Singaporean Life Science investment firm Zaluvida Holdings.

For more information, please visit inqpharm.com and zaluvida.com.
_________________________________

GRAZIX BECOMES NEW LIVELEAF SUBSIDIARY

May, 2014

LiveLeaf, Inc., San Carlos, CA has spun off its Grazix animal products division as a wholly owned subsidiary called Grazix Animal Health, Inc. Headquartered in Worthington, MN, Grazix Animal Health will be led by CEO Randy Simonson and will focus initially on the Porcine, Bovine and Cervine markets.

 Grazix is a family of next-generation natural animal health products, based on Reactive Plant Immunity, or RPI. It was developed by LiveLeaf Bioscience to address the significant challenges faced by veterinary professionals in maintaining healthy animal digestive balance in production environments

_________________________________

LIVELEAF SECURES IMPORTANT PARTNERSHIPS FOR THE EXPANSION OF LIFEDROPS

May, 2014

Over the next year, LifeDrops will implement pilot programs with two influential international partners: World Vision and Save the Children. World Vision works in nearly 100 countries helping children, families, and their communities to reach their full potential by tackling the causes of poverty and injustice. Save the Children works in 120 countries to save children’s lives, fight for their rights and help them achieve their full potential. LifeDrops will support ongoing partner programs in Kenya and Nigeria to improve child health and nutrition in vulnerable communities.

_________________________________

GRAZIX ANIMAL HEALTH, INC. JOINS MINNESOTA BIOTECHNOLOGY CENTER

July 14, 2014

WORTHINGTON, Minn. — New to join the Biotechnology Advancement Center is Grazix Animal Health, a family of next-generation natural animal health products based on reactive plant immunity (RPI).

Grazix products were first brought to the attention of Dr. Randy Simonson, who is now CEO and president of Grazix, a few years ago. “This product is derived from the company LiveLeaf, and a few years ago a graduate classmate of mine was in the area and told me about this plant-derived product,” Simonson explained. “I sort of dismissed it at first until I recognized all of these notable veterinarians who I respect … use this product.”

Simonson said LiveLeaf is a company based out of San Carlos, Calif., that originally developed products for people in third-world countries suffering from enteric diseases. Around 2009, the founders of LiveLeaf had discovered a way to isolate the compounds in living plants that were responsible for healing the plant when it became damaged. Testing began on these compounds on pig farms in China, and significant digestive benefits to humans and animals that consume these nutrients were found.

Thus the idea of Grazix was born, and LiveLeaf still continues to make products for human consumption. The RPI technology that both LiveLeaf and Grazix uses is patented and FDA-compliant. RPI is the technology that captures and stabilizes a natural-response mechanism so it can be activated by animal or human cellular enzymes, in order to mimic the original phytobiological process.“Right now Grazix has two products for swines and another one for calves, but we’re in the process in making products for other animals species as well,” Simonson said. The products are taken orally by the animals, and some can even be filtered into the water system from which they drink. “This technology truly is next-generation,” Simonson said. “We have distribution centers in Europe, and are in talks with China and Brazil.”  Currently, the Worthington facility has two full-time employees and one part-timer. The Worthington location is primarily for marketing and technical services, but Simonson plans to expand. “Right now the manufacturing and developing part of the product is still in San Carlos, but the long-term goal is to bring the manufacturing to Worthington,” he said. Grazix Animal Health is in the process of remodeling the two offices it currently rents and hopes to obtain the use of a laboratory.

LiveLeaf, Inc. article published in Alliance to End Hunger newsletter

_________________________________

GRAZIX BECOMES NEW LIVELEAF SUBSIDIARY.

May, 2014

LiveLeaf, Inc., San Carlos, CA has spun off its Grazix animal products division as a wholly owned subsidiary called Grazix Animal Health, Inc. Headquartered in Worthington, MN, Grazix Animal Health will be led by CEO Randy Simonson and will focus initially on the Porcine, Bovine and Cervine markets.

 Grazix is a family of next-generation natural animal health products, based on Reactive Plant Immunity, or RPI. It was developed by LiveLeaf Bioscience to address the significant challenges faced by veterinary professionals in maintaining healthy animal digestive balance in production environments

_________________________________

LIVELEAF SECURES IMPORTANT PARTNERSHIPS FOR THE EXPANSION OF LIFEDROPS

May, 2014

Over the next year, LifeDrops will implement pilot programs with two influential international partnersf: World Vision and Save the Children. World Vision works in nearly 100 countries helping children, families, and their communities to reach their full potential by tackling the causes of poverty and injustice. Save the Children works in 120 countries to save children’s lives, fight for their rights and help them achieve their full potential. LifeDrops will support ongoing partner programs in Kenya and Nigeria to improve child health and nutrition in vulnerable communities.

_________________________________

The 69th United Nations General Assembly Commences

September 24, 2014

Driving around New York this week, you may in fact have ample time to enjoy the first signs of fall. Unfortunately, this is likely because you have been halted by a passing motorcade. As world leaders descend on the city this week for the 69th opening plenary meeting of the United Nations General Assembly (UNGA) they will surely have more on their minds than the traffic. The conflict in Iraq and Syria along with the Ebola crisis in West Africa are both politically-charged issues that will command the media’s attention and that of the high-level attendees. At the same time, most in the development community will be focused on two important side events. The first, is the Climate Summit hosted by the UN to catalyze ambitious action on climate change. The second, is a series of meetings on women and children led by the Every Woman, Every Child Campaign and UNICEF on maternal and child health. We have less than 500 days left to achieve significant reductions in maternal and child mortality to meet Millennium Development Goals (MDGs) 4 and 5 before the 2015 deadline. In 2013, 6.3M children under-five died with a further 165M experiencing stunting as a result of malnutrition, micronutrient deficiency, maternal malnutrition and diarrhea. Reducing the burden of maternal and child mortality may seem like a daunting issue to address particularly given the challenges posed by limited budgets and crumbling health system infrastructure. If anything, the Ebola outbreak and its subsequent spread, have laid bare the risks of under-investing in healthcare systems and basic medical equipment. Here’s hoping that world leaders are able to shift their gaze this week toward the truly urgent issues that require their leadership: the health and future prosperity of their citizens. Perhaps the traffic will offer a rare moment of reflection.

_________________________________

WORLD WATER WEEK

September 2, 2014

Hundreds of organizations, academics and civil society leaders will meet in Stockholm this week to discuss the current state of water in the world. Having met MDG targets for halving the proportion of the population without access to safe drinking water, there is much to celebrate. Yet, despite progress, more than 750M people still lack sustainable access to clean water. The families left behind predominantly come from poor, rural areas and lack political capital to advocate for improvements to their water supply. Lack of access to water is felt most acutely by children. About 1.5 million children under-five die each year from water-related illness, the most common of which is diarrhea. Women and girls bear the brunt of the physical, economic and social burden, spending hours walking long distances to collect water from sources that are often contaminated. This is time not spent caring for family, generating income or attending school. For many families, things don’t seem to be improving and may be set to get much worse. According to the Swedish International Water Institute (SIWI), the conveners of the annual event in Stockholm, energy and water demands are expected to increase dramatically over the next 30 years, further straining finite and vulnerable resources. This challenge necessitates further investment by the international community in proven interventions and research into new technologies and programs that will close the gap. Countries with improved water and sanitation experience a seven fold reduction in infant mortality and a 15 minute reduction in time collecting water can increase the proportion of girls in school by almost 15%. In the meantime, saving lives today means addressing waterborne diseases as a matter of public health.

_________________________________

SUSTAINABLE DEVELOPMENT GOALS DRAFT AND COMMON AFRICAN POSITION RELEASED

June 6, 2014

After much anticipation, a draft of the post-2015 Sustainable Development Goals (SDGs) was released today by the UN-appointed working group. The draft highlights 17 goals to replace the Millennium Development Goals, which expire in 2015. High-level negotiations on the framework will begin in earnest at the September UN General Assembly meeting. Health is represented as goal number 3 of the proposed framework and includes a reference to ending [all] preventable newborn, infant and under-five deaths by 2030. Ending hunger and nutrition is mentioned as part of goal number 2 together with promoting improved food security, but is not linked directly to health. The goals are likely to undergo significant change over the course of the negotiations. The working group also re-committed to ensuring the international goals mirror national development plans. As such, the release of the Common African Position (CAP) on SDGs the day before was no coincidence. African governments stressed six pillars of interest including regional integration, trade, funding for innovation, research and technology, and infrastructure. Health also got a mention with African Governments renewing their pledged to honor the Abuja Declaration and spend at least 15% of their annual budget on improving healthcare. CAP also committed to ending maternal, child and infant mortality by 2030 in line with the SDG proposal.

_________________________________

LIVELEAF SECURES IMPORTANT PARTNERSHIPS FOR THE EXPANSION OF LIFEDROPS

May, 2014

Over the next year, LifeDrops will implement pilot programs with two influential international partners, World Vision and Save the Children. World Vision works in nearly 100 countries helping children, families, and their communities to reach their full potential by tackling the causes of poverty and injustice. Save the Children works in 120 countries to save children’s lives, fight for their rights and help them achieve their full potential. LifeDrops will support ongoing partner programs in Kenya and Nigeria to improve child health and nutrition in vulnerable communities.

_________________________________

TWO-YEAR ICDDR,B STUDY CONFIRMS COMPLETE SAFETY OF LIVELEAF-LIFEDROPS

January, 2014

The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) has confirmed the complete safety of LiveLeaf-LifeDrops, a product utilizing RPI. The two-year evaluation monitored segmented groups aged 60 years to 6 months over four days in the Short Stay Ward of icddr,b’s Dhaka Hospital. No adverse events were reported over the study period in any patient after lab and blood work were analyzed. Results also indicated effective resolution of acute diarrhea in non-cholera patients cutting recovery time in half. LiveLeaf is building on these results to evaluate the potential therapeutic benefits of RPI in children who lack safe, effective and affordable solutions.

_________________________________

LIVELEAF JOINS ALLIANCE TO END HUNGER

October, 2013

LiveLeaf has joined the Alliance to End Hunger, a coalition of 90 members dedicated to engaging multisector stakeholders in essential discussions around how governments and private actors can better serve their most vulnerable. The Alliance has recently been awarded a three-year, $2.9 million grant from USAID through President Obama’s Feed the Future Initiative to amplify the influence of civil society organizations in Kenya, Tanzania and Uganda in national policy discussions on agricultural development and food security. LiveLeaf is supporting the Alliance in these and others efforts to harness political will and affect policy change to address international child health and hunger issues.

_________________________________

LIVELEAF OPENS LIFEDROPS PROGRAM OFFICE IN NEW YORK

March, 2013

LiveLeaf has announced the opening of its LifeDrops program office in New York. The office will coordinate the expansion of the LifeDrops program for improving child health in the developing world. The new location will facilitate high-level engagement with change makers in New York and Washington, DC; this will in turn allow LiveLeaf to continue to create impactful programs for the dissemination of its reactive plant immunity (RPI) technology. The office is located at 394 Broadway, 5th Floor, New York, NY 10013.

_________________________________

Back to Main Page